Antonio Amoroso Selected Research

AT protocol

1/2022

Evaluation of Graft Fibrosis, Inflammation, and Donor-specific Antibodies at Protocol Liver Biopsies in Pediatric Liver Transplant Patients: A Single-center Experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Amoroso Research Topics

Disease

9	Infections 01/2021 - 03/2002
7	Fibrosis (Cirrhosis) 01/2022 - 12/2004
6	COVID-19 01/2022 - 01/2021
6	Thrombosis (Thrombus) 05/2014 - 06/2002
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2013 - 06/2002
5	Inflammation (Inflammations) 01/2022 - 02/2003
5	Primary hyperoxaluria type 1 06/2021 - 10/2001
5	Glomerulonephritis 09/2015 - 05/2006
4	Neoplasms (Cancer) 01/2017 - 07/2009
3	Food Hypersensitivity (Food Allergy) 01/2021 - 01/2016
3	Systemic Scleroderma (Systemic Sclerosis) 06/2018 - 09/2009
3	Milk Hypersensitivity (Milk Allergy) 06/2017 - 01/2016
3	Liver Diseases (Liver Disease) 08/2014 - 06/2007
3	Chronic Renal Insufficiency 08/2012 - 08/2011
3	Kidney Diseases (Kidney Disease) 04/2012 - 12/2004
3	Hypertension (High Blood Pressure) 08/2011 - 12/2009
3	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2010 - 06/2008
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2009 - 04/2006
3	Renal Insufficiency (Renal Failure) 01/2007 - 12/2004
2	Methylmalonic acidemia 01/2022 - 01/2020
2	Reperfusion Injury 01/2022 - 01/2021
2	Primary Hyperoxaluria (Oxaluria, Primary) 06/2021 - 09/2005
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 06/2007
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2021 - 02/2011
2	digital ulcers 06/2018 - 11/2017
2	Dysbiosis 06/2017 - 01/2016
2	Hepatitis C 01/2017 - 10/2016
2	Rhabdomyolysis 01/2015 - 08/2014
2	Vasculitis (Vasculitides) 01/2015 - 01/2013
2	Muscular Diseases (Myopathy) 01/2015 - 08/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2015 - 08/2014
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2014 - 08/2010
2	Disease Progression 07/2013 - 03/2002
2	Thrombocytopenia (Thrombopenia) 01/2013 - 02/2003
2	Hyperuricemia 04/2012 - 12/2004
2	Hepatocellular Carcinoma (Hepatoma) 12/2009 - 09/2005
2	Celiac Disease (Celiac Sprue) 04/2005 - 11/2002
1	Methylmalonic acidemia with homocystinuria 01/2022
1	Atypical Hemolytic Uremic Syndrome 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Hyperhomocysteinemia 01/2022
1	Brain Death (Brain Dead) 06/2021
1	Argininosuccinic Aciduria 01/2020

Drug/Important Bio-Agent (IBA)

5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 03/2006
5	Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA 11/2010 - 10/2001
4	AntibodiesIBA 01/2022 - 11/2002
4	CytokinesIBA 01/2016 - 06/2005
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2015 - 08/2005
4	Proteins (Proteins, Gene)FDA Link 07/2013 - 12/2009
4	UromodulinIBA 04/2012 - 05/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 03/2006
3	AntigensIBA 01/2017 - 08/2010
3	EnzymesIBA 08/2014 - 06/2009
3	Cysteine (L-Cysteine)FDA Link 12/2009 - 11/2002
3	Immunoglobulin G (IgG)IBA 08/2005 - 02/2003
3	LactoferrinIBA 08/2005 - 01/2002
2	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2011
2	EndostatinsIBA 06/2018 - 11/2017
2	Local Anti-Infective Agents (Antiseptics)IBA 06/2017 - 01/2016
2	Caseins (Casein)FDA Link 06/2017 - 01/2017
2	Peptides (Polypeptides)IBA 01/2017 - 09/2015
2	AutoantibodiesIBA 09/2015 - 01/2009
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2015 - 08/2014
2	IsoenzymesIBA 01/2015 - 08/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015 - 08/2014
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 08/2014 - 08/2010
2	Vasodilator Agents (Vasodilators)IBA 01/2014 - 06/2007
2	LeptinIBA 12/2013 - 02/2009
2	CreatinineIBA 08/2012 - 01/2007
2	Biological ProductsIBA 04/2012 - 12/2005
2	Histones (Histone)IBA 07/2009 - 06/2008
2	Antiphospholipid AntibodiesIBA 01/2009 - 07/2003
2	Immunoglobulin A (IgA)IBA 01/2009 - 05/2006
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 06/2007 - 03/2005
2	Phospholipids (Phosphatides)FDA LinkGeneric 06/2005 - 02/2003
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 04/2005 - 11/2002
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	bafilomycin A1IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	To autoantigenIBA 01/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022
1	Particulate MatterIBA 12/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Blood Group Antigens (Blood Groups)IBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2018
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018
1	Circular DNAIBA 01/2018
1	Angiogenesis InhibitorsIBA 11/2017
1	Volatile Fatty AcidsIBA 06/2017

Therapy/Procedure

5	Liver Transplantation 01/2022 - 09/2005
3	Transplantation 01/2022 - 01/2017
3	Kidney Transplantation 06/2021 - 09/2005
3	Therapeutics 09/2018 - 03/2006
2	Organ Transplantation 01/2021 - 01/2021
1	AT protocol 01/2022